Acquisitive Pfizer to strike again? Seagen back in M&A talks after Merck walked away: WSJ A potential buyout of Seagen by Pfizer—which was reported Sunday by The Wall Street Journal—makes “strategic sense for both parties and the antitrust hurdle appears surmountable,” Berenberg Capital Markets wrote in a note to investors. Log in or register to post comments
